|
|
||||||||
Vol. 84, Issue 3, 987-994, March 1998
Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
| |
ABSTRACT |
|---|
|
|
|---|
We investigated the effects of 3 wk of moderate- (21 m/min, 8% grade) and highintensity treadmill training (31 m/min, 15% grade) on 1) monocarboxylate transporter 1 (MCT-1) content in rat hindlimb muscles and the heart and 2) lactate uptake in isolated soleus (Sol) muscles and perfused hearts. In the moderately trained group MCT-1 was not increased in any of the muscles [Sol, extensor digitorum longus (EDL), and red (RG) and white gastrocnemius (WG)] (P > 0.05). Similarly, lactate uptake in Sol strips was also not increased (P > 0.05). In contrast, in the heart, MCT-1 (+36%, P < 0.05) and lactate uptake (+72%, P < 0.05) were increased with moderate training. In the highly trained group, MCT-1 (+70%, P < 0.05) and lactate uptake (+79%, P < 0.05) were increased in Sol. MCT-1 was also increased in RG (+94%, P < 0.05) but not in WG and EDL (P > 0.05). In the highly trained group, heart MCT-1 (+44%, P < 0.05) and lactate uptake (+173%, P < 0.05) were increased. In conclusion, it has been shown that 1) in both heart and skeletal muscle lactate uptake is increased only when MCT-1 is increased; 2) training-induced increases in MCT-1 occurred at a lower training intensity in the heart than in skeletal muscle; 3) in the heart, lactate uptake was increased much more after high-intensity training than after moderate-intensity training, despite similar increases in heart MCT-1 with these two training intensities; and 4) the increases in MCT-1 occurred independently of any changes in the heart's oxidative capacity (as measured by citrate synthase activity).
citrate synthase; soleus; extensor digitorum longus; red gastrocnemius; white gastrocnemius
| |
INTRODUCTION |
|---|
|
|
|---|
CONSIDERABLE EVIDENCE for a lactate transport system has been demonstrated in a variety of tissues, including the perfused rat hindquarter (40) and perfused rat heart (16), isolated intact muscles (2, 15), highly purified plasma membranes (23, 30), giant sarcolemmal vesicles (14, 18), and isolated cardiac myocytes (26, 37) and vesicles (34, 35). The above-mentioned studies have shown that the lactate carrier system in the heart and skeletal muscle functions as a stereoselective proton symport facilitating the electroneutral cotransport of H+ and lactate (13, 22, 29, 37).
Recently a monocarboxylate transporter (MCT-1) was cloned independently by two groups (4, 8, 9). In rats, MCT-1 is present in skeletal muscle and the heart (20) as well as in many other tissues (9). In skeletal muscles there is a high correlation between MCT-1 and 1) lactate uptake, 2) heart-type lactate dehydrogenase content, and 3) citrate synthase activity (20). Overexpression of MCT-1 in Chinese hamster ovary cells (32) or in chronically stimulated skeletal muscles (19) increased lactate uptake. This indicates that MCT-1 is a critical transport protein for the movement of lactate across the sarcolemma.
Muscle activity patterns may be an important determinant for establishing the capacity of lactate transport in muscle. When muscle activity is reduced by hindlimb unweighting (6) or denervation (17), lactate transport is decreased. After chronic muscle stimulation (18) and exercise training (21, 25), lactate transport is increased. The increase in muscle lactate transport capacity is also related to the intensity of training (25). Presumably, these changes in lactate transport in muscle occur in response to concurrent changes in MCT-1. However, there are no studies available to show whether the training-induced increase in lactate transport in skeletal muscle is associated with an increase in MCT-1, whether such changes are more prevalent in oxidative and/or glycolytic types of skeletal muscles, and whether the exercise training intensity influences the magnitude of the changes that can occur. In addition, there are no studies that have examined the influence of exercise training on lactate uptake by the heart. In this tissue the lactate transport system is the major route for the elimination of protons from myocytes (36).
We have investigated the effects of training on 1) MCT-1 in oxidative and glycolytic rat hindlimb muscles and in the heart and 2) lactate uptake in isolated perfused hearts and in isolated soleus (Sol) muscles. Because the increase in muscle lactate transport capacity is also related to the intensity of training (25), we also examined 3) the effects of two training programs, with different running intensities, on heart and muscle MCT-1 and lactate uptake. Furthermore, because it appears that some transport proteins in muscle are increased within days of the onset of exercise training [e.g., glucose transporter protein isoforms GLUT-1 and GLUT-4 (24, 28)], we examined 4) the training-induced changes in MCT-1 every week in muscles and heart for 3 wk in each of the two training programs. We hypothesized that MCT-1 and lactate uptake in the heart would not be affected by training but that, in skeletal muscle, MCT-1 and lactate uptake would 1) be increased with training and 2) be increased more with more intense training and 3) that the increase would be greater in oxidative types of skeletal muscles.
| |
METHODS |
|---|
|
|
|---|
Animal care and training programs.
Female Sprague-Dawley rats were housed in an air-conditioned room on a
12:12-h light-dark cycle. They were fed a diet of Purina rat chow and
water ad libitum. Animals commenced training between 10 and 12 wk of
age and were matched according to body weight as closely as possible.
Rats were randomly assigned to a control or to one of two
endurance-training groups. All rats were familiarized with a
motor-driven treadmill at low speeds (~15-20 m/min, 8% grade)
for ~5-10 min/day for 3-5 days. Control animals were either killed before initiation of training (day
0) or remained sedentary (limited to cage activity)
for the duration of the training program (day
20), at which point they were killed. For training
purposes the remaining rats were subdivided into either a
moderate-intensity (21 m/min, 8% grade) or a high-intensity (31 m/min,
15% grade) running group. In both groups training occurred 5 days each
week for 1 h/day for up to 3 wk. Because of the severity of treadmill running at 31 m/min up a 15% grade, the high-intensity trained group
required periodic rests for the first 2 days of training. Thereafter,
they ran continuously for 1 h each day. Each week some of the animals
(n = 4-5) were killed, 24 h after
the last training session, with an intraperitoneal injection of
pentobarbital sodium (65 mg/100 g body wt). While animals were under
anesthesia, before death occurred, heparin (500 IU/kg) was administered
intravenously. Skeletal muscles [red (RG) and white gastrocnemius
(WG), extensor digitorum longus (EDL), and Sol] were rapidly
removed, frozen in liquid nitrogen, and stored at
80°C until
analyzed for MCT-1 and citrate synthase activity. Lactate uptake was
determined in fresh strips of isolated rat Sol muscles and in isolated,
perfused rat hearts.
Lactate uptake by isolated perfused myocardium.
Thirty seconds after the heparin was administered, hearts were rapidly
excised and placed in perfusion buffer at 4°C. Isolated rat hearts
were perfused in the Langendorff mode as described by Ferdinandy et al.
(7). Briefly, each heart was immediately cannulated through the aorta
and preperfused at 37°C, in a retrograde manner, at a constant
perfusion pressure equivalent to 100 cm of water (10 kPa). The
preperfusion medium consisted of a modified Krebs-Henseleit bicarbonate
buffer (KHBB) containing (in mM) 118 NaCl, 4.3 KCl, 2.4 CaCl2, 25 NaHCO3, 1.2 KH2PO4,
1.2 MgSO4, and 10 glucose, gassed
continually with 95% O2-5%
CO2 (pH 7.4 at 37°C). After 15 min, the hearts were then perfused with glucose-free KHBB containing 1 mM unlabeled lactate as substrate and 5 µCi of
L-[U-14C]lactate
and 5 µCi of
D-[1-3H]sorbitol.
All perfusate was filtered to remove any precipitated or particulate
contaminants. In preliminary experiments we found that a 90-s perfusion
period was sufficient to equilibrate the radiolabel in the perfused
hearts while at the same time lactate uptake was still increasing
linearly and oxidation was minimal (<10%). We did not take this
small fraction of oxidized lactate into account in our studies. This
has also been done in other studies when lactate oxidation was low
[cf. Refs. 2, 15, 23 (text and references)]. At the end of
the 90-s perfusion period, a small portion of the left ventricle (~50
mg) was obtained, blotted, and frozen in liquid nitrogen. The samples
were stored at
80°C until analyzed for
14C and
3H in digested extracts (2, 17,
23). The remainder of the heart was dissected free of great vessels and
atria and used for citrate synthase and MCT-1 determinations. All
samples were stored at
80°C until analyzed.
Lactate uptake into intact skeletal muscle in vitro.
Lactate uptake measurements were performed as previously described (2,
17, 23) in strips of Sol muscles (17). Briefly, the Sol muscle was
separated from underlying connective tissue, and the lateral sections
were stripped longitudinally into small strips from tendon to tendon by
using a needle. Sol strips were then preincubated in 1.5 ml of gassed
(95% O2-5%
CO2) KHBB containing 10 mM
glucose and 0.2% fatty acid-free bovine serum albumin (BSA) at
37°C for 15 min in a shaking water bath (80 cycles/min). The muscles were then transferred to new incubation vials that contained 1.5 ml of gassed KHBB, 0.2% BSA, 1 mM unlabeled lactate, 1 µCi L-[U-14C]lactate,
and 1 µCi
D-[1-3H]sorbitol.
In preliminary time course experiments, an incubation time of 5 min
provided the optimal measurement point for lactate uptake in Sol muscle
strips because lactate oxidation was low (<15%), lactate uptake was
in the linear range, and
D-[1-3H]sorbitol
had equilibrated with the extracellular compartment. To terminate
lactate uptake, Sol strips were rapidly removed from the incubation
medium, rinsed in 0.9% ice-cold saline, cut free of tendons, and
snap-frozen in liquid nitrogen. The samples were stored at
80°C until analyzed for
14C and
3H in digested muscle extracts (2,
17, 23).
Sample preparation for Western blotting.
Proteins were isolated from muscles (Sol, EDL, RG, and WG) and the
heart for Western blotting as previously described (20). Briefly,
muscles (~50 mg) were homogenized in 2 ml of buffer
A [(in mM) 210 sucrose, 2 ethylene
glycol-bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic acid, 40 NaCl, 30 N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 5 EDTA, and 2 phenylmethylsulfonyl fluoride, pH 7.4] for two interrupted 15-s bursts with a Polytron homogenizer set at eight.
Homogenates were transferred to centrifuge tubes, and 2 ml of
buffer A, used to rinse the Polytron,
were added to the tubes. Then, 3 ml of buffer
B (1.167 M KCl, 58.3 mM tetrasodium pyrophosphate) were
added, mixed briefly, and then set on ice for 15 min. After
centrifugation at 230,000 g for 75 min
at 4°C, the supernatant fluid was discarded and the pellet was
washed thoroughly with 1-2 ml of buffer
C [10 mM tris(hydroxymethyl)aminomethane (Tris)
base and 1 mM EDTA, pH 7.4]. The pellet was resuspended in 600 µl of buffer C and homogenized for
two interrupted 10-s bursts with a Polytron set at seven. Then, 200 µl of 16% sodium dodecyl sulfate were added, samples were removed
from ice, vortex mixed, and centrifuged at 1,100 g for 20 min at room temperature. The
supernatant was divided into aliquots and stored at
80°C for
protein assay and immunoblot detection of MCT-1.
Western blotting of MCT-1. A polyclonal anti-peptide antibody similar to that used by Garcia et al. (9) directed against the COOH terminus of MCT-1 was produced by immunizing New Zealand White rabbits with a synthetic peptide corresponding to amino acids 478-494 of MCT-1. This antibody was raised and affinity purified as described elsewhere (4). The polyclonal antibody yielded a single band on a Western blot that corresponded to a molecular weight of ~43,000, consistent with the molecular weight reported for MCT-1 (8, 9). In preliminary work, MCT-1 detection was blocked by the synthetic peptide and MCT-1 was found to be abundant in rat red blood cell ghosts as expected (data not shown).
Protein samples of the muscles (30-60 µg) and heart (10 µg), a pooled rat heart standard (10 µg), and prestained molecular weight markers (Bio-Rad) were separated on 12% sodium dodecyl sulfate-polyacrylamide gels (150 V for 1 h). Proteins were then transferred from the gel to Immobilon polyvinylidene difluoride membranes (100 V, 90 min). Membranes were incubated on a shaker overnight (~16 h) in buffer D [20 mM Tris base, 137 mM NaCl, 0.1 M HCl, pH 7.5, 0.1% (vol/vol) Tween 20, and 10% (wt/vol) nonfat dried milk] at room temperature. Membranes were then incubated with diluted COOH-terminus MCT-1 antibody (1:3,000) in buffer D for 2 h, followed by three washes in buffer E (i.e., buffer D without dried milk: 15-min wash and 2 × 5-min washes) and by incubation for 1 h with donkey anti-rabbit immunoglobulin G horseradish peroxidase-conjugated secondary antibody (1:3,000; NA 934, Amersham) in buffer E. Membranes were washed as before with buffer E, and then MCT-1 was detected by using an enhanced chemiluminescence detection method by exposing the membranes to film (Hyperfilm-ECL; Amersham) at room temperature according to the instructions of the manufacturer (Amersham). Film was developed in developer (Kodak) and fixed in GBX fixer/replenisher (Kodak). MCT-1 protein band densities were obtained by scanning the blots on a densitometer connected to a Macintosh LC computer with appropriate software.Citrate synthase determination.
To monitor the mitochondrial adaptation to endurance training, the Sol,
EDL, RG, WG, and the heart were assayed via a standard fluorometric
method (5) for maximal citrate synthase activity after the third week
of training at both intensities (i.e., moderate and high) and in
control animals. Briefly, 5-10 mg of tissue were homogenized in
250 µl buffer [(in mM) 16 Na2HPO4,
4 KH2PO4,
5 2-mercaptoethanol, 0.5 mM EDTA as well as 0.02% BSA and 50%
(vol/vol) glycerol, pH 7.4] by using a glass pestle. Homogenates
were sonicated and stored frozen at
80°C. Homogenates were
diluted 50-fold in 20 mM imidazole-HCl, 0.02% charcoal-filtered BSA.
This diluted homogenate (10 µl) was used in the assay that was
started by adding 100 µl of reagent
1 (50 mM Tris · HCl, 0.4 mM
acetyl-CoA, 0.5 mM oxaloacetate, 0.25% BSA, pH 8.1) and allowed to
react for 1 h at room temperature (this reaction is linear for more
than 1 h). Ten microliters of 0.5 N NaOH was added, and the
sample was heated to 95°C for 5 min. One milliliter of
reagent 2 (100 mM Tris · HCl, 100 µM
ZnCl2, 0.01% BSA, 30 µM NADH,
0.003 U/ml citrate lyase, 3 U/ml malate dehydrogenase, pH 7.5) was
added and left for 20 min, after which 60 µl of 1 N HCl were added,
left for 10 min, followed by 100 µl of 6 N NaOH/imidazole, and heated
to 60°C for 20 min. Citric acid standards were also included in the assay. The 6 N NaOH converts NAD+
to a highly fluorescent compound that was read on a fluorometer.
Statistical analysis. A one-way analysis of variance was used to analyze the effects of training on cardiac and individual skeletal muscle MCT-1 contents and citrate synthase activities. Lactate uptake data were assessed with a t-test. All data are reported as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
The mean body weights of all the animals before training was 248 ± 3.0 g (n = 46). The moderately trained animals (21 m/min, 8% grade, 5 × 1 h/wk) gained ~20 g/wk over the 3-wk training period. This resulted in a 24% increase over their pretraining weights (P < 0.05), and this increase was similar to the weight gain during the 3-wk period in the control group (P > 0.05). In the high-intensity trained group (31 m/min, 15% grade, 5 × 1 h/wk), weight gains were more modest (5 g/wk), resulting in a net weight gain of 7% by the end of the third week of training (P < 0.05). This weight gain in the high-intensity trained group was lower than in the moderately trained and control groups (P < 0.05).
Heart and muscle citrate synthase activity. No changes were observed in citrate synthase activity in any of the skeletal muscles in the moderately trained group after 3 wk of training (P > 0.05). In the high-intensity trained group, training caused a significant increase in citrate synthase activity in Sol (+69%) and RG (+37%) (P < 0.05) but not in the EDL and the WG (P > 0.05) (Fig. 1). In the heart, citrate synthase activity was not increased in either the moderately trained or high-intensity trained groups (P > 0.05) (Fig. 1).
|
MCT-1 in heart and skeletal muscles. With Western blotting we were able to detect a single band for MCT-1 in skeletal muscles and heart from trained and untrained animals (Fig. 2). This corresponds to observations in previous studies from our laboratory (19, 20). MCT-1 content was greatest in the heart (Fig. 3). There was a strong relationship between the mean values of citrate synthase activities and the MCT-1 content of the tissues (r = 0.98, Fig. 3).
|
|
MCT-1 adaptations in metabolically heterogeneous skeletal muscles. In the moderately trained group, no changes were observed in MCT-1 content in Sol, RG, EDL, and WG muscles during the 3-wk training period (Fig. 4) (P > 0.05). With the higher intensity training, MCT-1 was increased by 70% in the Sol (P < 0.05) and 94% in the RG (P < 0.05) muscles at the end of the 3-wk training period (Fig. 4). This increase was already apparent after the first week of training in both muscles, with an increase of 30% in Sol MCT-1 content (P < 0.05) and an increase of 32% in the RG MCT-1 content (P < 0.05). In contrast, MCT-1 was not changed in either the EDL or WG with the high-intensity training (P > 0.05) (Fig. 4).
|
MCT-1 adaptations in the heart. MCT-1 content in the heart increased progressively with moderate training (Fig. 5, P < 0.05), attaining a 36% increase after 3 wk (i.e., 15 h) of running. When the training intensity was increased, a progressive MCT-1 increase was also observed in the heart (Fig. 5, P < 0.05), attaining a 44% increase after 3 wk (i.e., 15 h) of training (P < 0.05). Changes in MCT-1 in the heart between moderately trained and high-intensity trained animals did not differ (P > 0.05).
|
Lactate uptake in skeletal muscles. Lactate uptake into incubated Sol muscle strips from sedentary control animals on days 0 and 20 did not differ (P > 0.05). Therefore, these data were pooled. At the end of the training period, lactate uptake in the moderately trained and control Sol muscle strips did not differ (Fig. 6, P > 0.05). In contrast, there was a marked increase (+79%) in lactate uptake by the Sol muscles from the high-intensity trained group (P < 0.05) (Fig. 6).
|
Lactate uptake in the heart. No changes in myocardial lactate uptake were observed in control animals between days 0 and 20 (P > 0.05). These data were therefore pooled. After 3 wk of training, lactate uptake was increased in both the moderately trained (+72%) and high-intensity trained groups (+173%) (P < 0.05) compared with in the control animals (Fig. 6). The increase in the high-intensity trained group was significantly greater than in the moderately trained group (P < 0.05) (Fig. 6).
| |
DISCUSSION |
|---|
|
|
|---|
This is the first study to show that MCT-1 can be increased in heart and skeletal muscles by exercise training. In skeletal muscles we found that 1) MCT-1 was increased only when the training intensity of training was high, 2) the MCT-1 increase occurred only in highly oxidative skeletal muscles (i.e., Sol and RG) not in glycolytic muscles (i.e., EDL and WG), and 3) in the Sol muscle, lactate uptake increased only when MCT-1 was also increased. In the heart we observed that 4) MCT-1 was increased at a lower training intensity than in skeletal muscles, 5) MCT-1 did not increase further when the training intensity was increased, 6) the increase in MCT-1 occurred independently of changes in the heart's oxidative capacity (as measured by citrate synthase activity), and 7) lactate uptake was increased much more after high-intensity training than after moderate-intensity training, despite similar increases in heart MCT-1 with these two training intensities.
MCT-1 and lactate uptake in control muscles and heart. In the present study the greater concentrations of MCT-1 in more oxidative types of muscles, the high correlation between MCT-1 and citrate synthase activity, and the greater MCT-1 content in the heart than in skeletal muscles confirm recent observations from this laboratory (20). On the basis of the greater concentrations of MCT-1 in oxidative muscles (present study, Refs. 19 and 20), and the correlations between MCT-1 and citrate synthase activity (present study, Ref. 20) and MCT-1 and heart-type lactate dehydrogenase content (20), we suggest that the primary role of MCT-1 is to facilitate the movement of lactate into the muscle cell and to dispose of this substrate via oxidative metabolism because the rate of glyconeogenesis in highly oxidative muscles is low (1, 3). Lactate uptake by the muscle cell can be from the the circulation and from nearby fibers in which lactate is produced. In the heart MCT-1 is primarily located on myocyte membranes facing each other, suggesting that MCT-1 facilitates the transfer of lactate and protons from myocyte to myocyte (12).
Effects of training on MCT-1. Training increased MCT-1 in the heart and only in some of the muscles. In the heart, MCT-1 increments occurred at the low training intensity (21 m/min, 8% grade, 1 h/day). Increasing the training intensity (31 m/min, 15% grade, 1 h/day) did not not result in a further increase in heart MCT-1 content. In contrast, skeletal muscle MCT-1 was increased only in the oxidative muscles (Sol and RG) and only with the higher running intensity (31 m/min, 15% grade, 1 h/day). Thus in Sol and RG there was clearly a critical level of running activity required before an increase in MCT-1 was observed. Presumably, at the higher training intensity all the muscles examined (Sol, RG, WG and EDL) were recruited, but it appears that the contractile activities of the WG and EDL were not sufficient to provoke changes in MCT-1. Although glycolytic muscle fibers contain little or no MCT-1 protein (20), MCT-1 content of these fibers can be increased because chronic electrical stimulation of the EDL elicited a large increase in MCT-1 (19). This lends credence to our argument that an adequate contraction stimulus is required, particularly in glycolytic muscles, before increases in MCT-1 will be observed.
When increases in MCT-1 did occur, either in the heart or skeletal muscles, these were observed within a few days of the onset of training. Already within the first week of training there was an ~20% increase in MCT-1 in the heart (moderate- and high-intensity training) and a 30% increase in MCT-1 in skeletal muscles (Sol, RG: high-intensity training only). Others have noted previously that the glucose transporter protein GLUT-4 in skeletal muscle is also increased in the first few days of training (10, 24, 28). Why MCT-1 is increased at a lower training workload in heart than in skeletal muscle is not known. Nevertheless, it may be advantageous to increase MCT-1 in the heart, to facilitate the extrusion of protons from ischemic cells (36). In skeletal muscles the increase in MCT-1 appears to be on the same order of magnitude as the increases in the muscles' oxidative capacities. However, in the heart, which already has a very high oxidative capacity, the increase in MCT-1 occurred in the absence of any changes in citrate synthase activity. Other training programs of greater duration and intensity have also failed also to induce a change in the heart's oxidative capacities (27, 33). In human skeletal muscle we have found that MCT-1 (unpublished data) can be increased with training before there are any changes in the maximal O2 uptake or in the oxidative capacities of the muscle, as we have also observed for GLUT-1 and GLUT-4 (24). Thus it appears that, with training, an increase in substrate transport proteins can occur before there are measurable changes in the oxidative capacities of skeletal muscles.Lactate uptake and MCT-1. It would be desirable to use a nonmetabolizable analog of lactate to examine the transport of this substrate. However, such an analog is not available. Therefore, in this study, as well as in others, we have used short incubation (2, 17) or perfusion periods (19, 20) to minimize the oxidation of lactate. In this manner, the lactate that accumulates in the tissue provides an index of lactate transport. Previously, it has been shown that lactate uptake in isolated Sol muscles and lactate transport into sarcolemmal vesicles are reasonably comparable (23). Therefore, we feel that the tissue lactate accumulation in this study provides a reasonable index of lactate transport.
In the Sol muscle there was no change in MCT-1 content or lactate uptake after training at moderate intensity, but there was an increase in both MCT-1 and an increase in lactate uptake with high-intensity training. Thus, on the basis of the results in the Sol muscle, it appears that an increase in lactate uptake occurs only when there has been an increase in MCT-1 content in the muscle. Whether this is also true in the other muscles cannot be stated with certainty because their lactate uptake capacities were not examined. Recently, it has been shown that MCT-1, when overexpressed in Chinese hamster ovary cells, increases lactate uptake (31). Similarly, we have shown a high correlation between the increase in MCT-1 and the increase in lactate uptake in chronically stimulated muscles (19). This was also observed in the present study because the increase in Sol lactate uptake (+78%) was similar to the increase in MCT-1 (+70%) in this muscle. This concordant relationship between increases in MCT-1 and lactate uptake in muscle may indicate that only one monocarboxylate transporter protein (i.e., MCT-1) is being increased when skeletal muscle activity is increased, by training (present study) or chronic electrical stimulation (19). In contrast to the Sol muscle, the results in the heart suggest that more than one monocarboxylate transporter may have been increased. This is based on the observation that the increases in MCT-1 in the heart were similar with the two training programs, but the increase in lactate uptake was much greater with high-intensity training than with low-intensity training. Two MCT isoforms have been identified to date, and these are apparently coexpressed in the heart and oxidative skeletal muscles (8). However, we have had difficulty detecting any MCT-2 protein in heart and muscle (unpublished data), although the MCT-2 protein is present in liver (Ref. 8, unpublished data). We have isolated MCT-2 mRNA in heart and muscle, but this transcript is barely detectable in these tissues (unpublished data). In contrast, MCT-1 mRNA is abundantly observed in both muscles and heart (unpublished data). Despite these observations, there is considerable kinetic evidence to suggest that there are at least two monocarboxylate transporters in the heart (37-39). Failure of the MCT-2 antibody to detect any protein in the heart prevented us from determining conclusively whether MCT-2 is expressed in the heart and whether training could increase this transporter. Alternatively, it is possible that another as yet unidentified MCT transporter is coexpressed with MCT-1 in the heart. The changes in this transporter could well differ from the changes in MCT-1, and this would begin to account for the very great increase in lactate uptake in hearts from the rats in the high-training-intensity group. We have previously reported that glucose transporter isoforms (GLUT-4 and GLUT-1) can increase disproportionately when exposed to the same chronic contraction stimulus in skeletal muscle (11). In summary, we have shown that with moderate or intense treadmill training, the heart MCT-1 content was increased by about the same extent, whereas lactate uptake was increased much more in the hearts from intensely trained animals. In contrast, MCT-1 was not increased in any of the skeletal muscles with moderate training, whereas an increase in MCT-1 was observed with high-intensity training, but only in the oxidative skeletal muscles, not in the glycolytic muscles. In Sol muscle, lactate uptake was increased only when MCT-1 content was also increased. These studies have shown that MCT-1 content and lactate uptake can be increased with training in both the heart and skeletal muscles. However, the threshold for inducing these changes is lower in the heart than in skeletal muscles.| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. A. P. Halestrap, Department of Biochemistry, University of Bristol, United Kingdom, for providing the monocarboxylate transporter 1 antibody.
| |
FOOTNOTES |
|---|
This study was supported by National Sciences and Engineering Research Council of Canada.
Address for reprint requests: A. Bonen, Dept. of Kinesiology, Univ. of Waterloo, Waterloo, Ontario, Canada N2L 3G1 (E-mail: abonen{at}healthy.uwaterloo.ca).
Received 9 May 1997; accepted in final form 13 November 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bonen, A.,
and
D. Homonko.
Effects of exercise and glycogen depletion on glyconeogenesis in muscle.
J. Appl. Physiol.
76:
1753-1758,
1994
2.
Bonen, A.,
and
K. J. A. McCullagh.
Effects of exercise on lactate transport into mouse skeletal muscles.
Can. J. Appl. Physiol.
19:
275-285,
1994[Medline].
3.
Bonen, A.,
J. C. McDermott,
and
M. H. Tan.
Glycogenesis and glyconeogenesis in skeletal muscle: effects of pH and hormones.
Am. J. Physiol.
258 (Endocrinol. Metab. 21):
E693-E700,
1990
4.
Carpenter, L.,
R. C. Poole,
and
A. P. Halestrap.
Cloning and sequencing of the monocarboxylate transporter from mouse Ehrlich-Lettre tumour cells confirms its identity as MCT-1 and demonstrates that glycosylation is not required for MCT-1 function.
Biochim. Biophys. Acta
1279:
157-163,
1996[Medline].
5.
Chi, M. M.-Y.,
C. S. Hintz,
E. F. Coyle,
W. H. Martin,
J. L. Ivy,
P. M. Nemeth,
J. O. Holloszy,
and
O. H. Lowry.
Effects of detraining on enzymes of energy metabolism in individual human muscle fibers.
Am. J. Physiol.
244 (Cell Physiol. 13):
C276-C287,
1983
6.
Dubouchaud, H.,
P. Granier,
J. Mercier,
C. Le Peuch,
and
C. Prefaut.
Lacate uptake by skeletal muscle sarcolemmal vesicles decreases after 4 wk of hindlimb unweighting in rats.
J. Appl. Physiol.
80:
416-421,
1996
7.
Ferdinandy, P.,
M. Koltai,
A. Tosaki,
P. Berthet,
T. Tarrade,
A. Esanu,
and
P. Braquet.
Cicletanine improves myocardial function deteriorated by ischemia/reperfusion in isolated working hearts.
J. Cardiovasc. Pharmacol.
19:
181-189,
1992[Medline].
8.
Garcia, C. K.,
M. S. Brown,
R. K. Pathak,
and
J. L. Goldstein.
cDNA cloning of MCT-2, a second monocarboxylate transporter expressed in different cells than MCT-1.
J. Biol. Chem.
270:
1843-1849,
1995
9.
Garcia, C. K.,
J. L. Goldstein,
R. K. Pathak,
G. W. Anderson,
and
M. S. Brown.
Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle.
Cell
76:
865-873,
1994[Medline].
10.
Henriksen, E. J.,
and
A. E. Halseth.
Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats.
J. Appl. Physiol.
76:
1862-1867,
1994
11.
Johannsson, E.,
K. J. A. McCullagh,
X.-X. Han,
P. K. Fernando,
J. Jensen,
H. A. Dahl,
and
A. Bonen.
Effect of overexpressing GLUT-1 and GLUT-4 on insulin- and contraction-stimulated glucose transport in muscle.
Am. J. Physiol.
271 (Endocrinol. Metab. 34):
E547-E555,
1996
12.
Johannsson, E., E. A. Nagelhus, K. J. A. McCullagh, O. M. Sejersted, T. W. Blackstad, A. Bonen, and O.-P. Otterson. Cellular and subcellular expression of
the monocarboxylate transporter MCT-1 in rat heart. A high resolution
immunogold analysis. Circ. Res.
400-407, 1997.
13.
Juel, C.
Symmetry and pH dependency of the lactate/proton carrier in skeletal muscle studied with rat sarcolemmal giant vesicles.
Biochim. Biophys. Acta
1283:
106-110,
1996[Medline].
14.
Juel, C.,
A. Honig,
and
H. Pilegaard.
Muscle lactate transport studied in sarcolemmal giant vesicles: dependence on fiber type and age.
Acta Physiol. Scand.
143:
361-365,
1991[Medline].
15.
Juel, C.,
and
F. Wibrand.
Lactate transport in isolated mouse muscles studied with a tracer technique
kinetics, stereospecificity, pH dependency and maximal capacity.
Acta Physiol. Scand.
137:
33-39,
1989[Medline].
16.
Mann, G. E. B.,
B. V. Zlokovic,
and
D. L. Yudilevich.
Evidence for lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier, specificity and effects of glucagon.
Biochim. Biophys. Acta
19:
241-248,
1985.
17.
McCullagh, K. J. A.,
and
A. Bonen.
Reduced lactate transport in denervated rat skeletal muscle.
Am. J. Physiol.
269 (Regulatory Integrative Comp. Physiol. 38):
R884-R888,
1995.
18.
McCullagh, K. J. A.,
C. Juel,
M. O'Brien,
and
A. Bonen.
Chronic muscle stimulation increases lactate transport in rat skeletal muscle.
Mol. Cell. Biochem.
156:
51-57,
1996[Medline].
19.
McCullagh, K. J. A.,
R. C. Poole,
A. P. Halestrap,
M. O'Brien,
and
A. Bonen.
Chronic electrical stimulation increases MCT-1 and lactate uptake in red and white skeletal muscle.
Am. J. Physiol.
273 (Endocrinol. Metab. 36):
E239-E246,
1997
20.
McCullagh, K. J. A.,
R. C. Poole,
A. P. Halestrap,
M. O'Brien,
and
A. Bonen.
Role of the lactate transporter (MCT-1) in skeletal muscles.
Am. J. Physiol.
271 (Endocrinol. Metab. 34):
E143-E150,
1996
21.
McDermott, J. C.,
and
A. Bonen.
Endurance training increases skeletal muscle lactate transport.
Acta Physiol. Scand.
147:
323-327,
1993[Medline].
22.
McDermott, J. C.,
and
A. Bonen.
Lactate transport by skeletal muscle sarcolemmal vesicles.
Mol. Cell. Biochem.
122:
113-121,
1993[Medline].
23.
McDermott, J. C.,
and
A. Bonen.
Lactate transport in rat sarcolemmal vesicles and intact skeletal muscle, and after muscle contraction.
Acta Physiol. Scand.
151:
17-28,
1994[Medline].
24.
Phillips, S.,
X.-X. Han,
H. J. Green,
and
A. Bonen.
Increments in skeletal muscle GLUT-1 and GLUT-4 after endurance training in humans.
Am. J. Physiol.
270 (Endocrinol. Metab. 33):
E456-E462,
1996
25.
Pilegaard, H.,
C. Juel,
and
F. Wibrand.
Lactate transport studied in sarcolemmal giant vesicles from rats: effects of training.
Am. J. Physiol.
264 (Endocrinol. Metab. 27):
E156-E160,
1993
26.
Poole, R. C.,
S. L. Cranmer,
A. P. Halestrap,
and
A. J. Levi.
Substrate and inhibitor specificity of monocarboxyolate transport into heart cells and erythrocytes.
Biochem. J.
269:
827-829,
1990[Medline].
27.
Powers, S. K.,
D. Criswell,
J. Lawler,
D. Martin,
F. K. Liue,
L. L. Ji,
and
R. A. Herb.
Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H2094-H2098,
1993
28.
Ren, J. M.,
C. F. Semenkovich,
E. A. Gulve,
J. Gao,
and
J. O. Holloszy.
Exercise induces rapid increases in GLUT-4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle.
J. Biol. Chem.
269:
14396-14401,
1994
29.
Roth, D. A.,
and
G. A. Brooks.
Lactate and pyruvate transport is dominated by a pH gradient-sensitive carrier in rat skeletal muscle sarcolemmal vesicles.
Arch. Biochem. Biophys.
279:
386-394,
1990[Medline].
30.
Roth, D. A.,
and
G. A. Brooks.
Lactate transport is mediated by a membrane-bound carrier in rat skeletal muscle sarcolemmal membranes.
Arch. Biochem. Biophys.
279:
377-385,
1990[Medline].
31.
Takanaga, H.,
I. Tamai,
S. Inaba,
Y. Sai,
H. Higashida,
H. Yamamoto,
and
A. Tsuji.
cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter.
Biochem. Biophys. Res. Commun.
217:
370-377,
1995[Medline].
32.
Tamai, I.,
H. Takanaga,
H. Maeda,
Y. Sai,
T. Ogihara,
H. Higashida,
and
A. Tsuji.
Participation of a proton-cotransporter, MCT-1, in the intestinal transport of monocarboxylic acids.
Biochem. Biophys. Res. Commun.
214:
482-489,
1995[Medline].
33.
Tidiius, P. M.,
and
M. E. Houston.
Antioxidant and oxidative enzyme adaptations to vitamin E deprivation and training.
Med. Sci. Sports Exerc.
26:
354-359,
1994[Medline].
34.
Trosper, T. L.,
and
K. D. Philipson.
Functional characteristics of the cardiac sarcolemmal monocarboxylate transporter.
J. Membrane Biol.
112:
15-23,
1989[Medline].
35.
Trosper, T. L.,
and
K. D. Philipson.
Lactate transport by cardiac sarcolemmal vesicles.
Am. J. Physiol.
252 (Cell Physiol. 21):
C483-C489,
1987
36.
Vandenberg, J. I.,
J. C. Metcalfe,
and
A. A. Grace.
Mechanisms of pHi recovery after global ischemia in the perfused heart.
Circ. Res.
72:
993-1003,
1993
37.
Wang, X.,
A. J. Levi,
and
A. P. Halestrap.
Kinetics of the sarcolemmal lactate carrier in single heart cells using BCECF to measure pHi.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H1759-H1769,
1994
38.
Wang, X.,
A. J. Levi,
and
A. P. Halestrap.
Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H476-H484,
1996
39.
Wang, X.,
R. C. Poole,
A. P. Halestrap,
and
A. J. Levi.
Characterization of the inhibition by stilbene disulphonates and phloretin of lactate and pyruvate transport into rat and guinea-pig cardiac myocytes suggests the presence of two kinetically distinct carriers in heart cells.
Biochem. J.
290:
249-258,
1993.
40.
Watt, P. W.,
P. A. MacLennan,
H. S. Hundal,
C. M. Kuret,
and
M. J. Rennie.
L(+)-Lactate transport in perfused rat skeletal muscle: kinetic characteristics and sensitivity to pH and transport inhibitors.
Biochim. Biophys. Acta
944:
213-222,
1988[Medline].
This article has been cited by other articles:
![]() |
C. Thomas, D. Bishop, T. Moore-Morris, and J. Mercier Effects of high-intensity training on MCT1, MCT4, and NBC expressions in rat skeletal muscles: influence of chronic metabolic alkalosis Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E916 - E922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, R. Hussien, S. Oommen, K. Gohil, and G. A. Brooks Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis FASEB J, August 1, 2007; 21(10): 2602 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Burgomaster, N. M. Cermak, S. M. Phillips, C. R. Benton, A. Bonen, and M. J. Gibala Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1970 - R1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mohr, P. Krustrup, J. J. Nielsen, L. Nybo, M. K. Rasmussen, C. Juel, and J. Bangsbo Effect of two different intense training regimens on skeletal muscle ion transport proteins and fatigue development Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1594 - R1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Philp, A. L. Macdonald, and P. W. Watt Lactate - a signal coordinating cell and systemic function J. Exp. Biol., December 15, 2005; 208(24): 4561 - 4575. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Thomas, S. Perrey, K. Lambert, G. Hugon, D. Mornet, and J. Mercier Monocarboxylate transporters, blood lactate removal after supramaximal exercise, and fatigue indexes in humans J Appl Physiol, March 1, 2005; 98(3): 804 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Coles, J. Litt, H. Hatta, and A. Bonen Exercise rapidly increases expression of the monocarboxylate transporters MCT1 and MCT4 in rat muscle J. Physiol., November 15, 2004; 561(1): 253 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hashimoto, N. Kambara, R. Nohara, M. Yazawa, and S. Taguchi Expression of MHC-{beta} and MCT1 in cardiac muscle after exercise training in myocardial-infarcted rats J Appl Physiol, September 1, 2004; 97(3): 843 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshida, H. Hatta, M. Kato, T. Enoki, H. Kato, and A. Bonen Relationship between skeletal muscle MCT1 and accumulated exercise during voluntary wheel running J Appl Physiol, August 1, 2004; 97(2): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Enoki, Y. Yoshida, H. Hatta, and A. Bonen Exercise training alleviates MCT1 and MCT4 reductions in heart and skeletal muscles of STZ-induced diabetic rats J Appl Physiol, June 1, 2003; 94(6): 2433 - 2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hatta, M. Tonouchi, D. Miskovic, Y. Wang, J. J. Heikkila, and A. Bonen Tissue-specific and isoform-specific changes in MCT1 and MCT4 in heart and soleus muscle during a 1-yr period Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E749 - E756. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Johannsson, P. K. Lunde, C. Heddle, I. Sjaastad, M. J. Thomas, L. Bergersen, A. P. Halestrap, T. W. Blackstad, O. P. Ottersen, and O. M. Sejersted Upregulation of the Cardiac Monocarboxylate Transporter MCT1 in a Rat Model of Congestive Heart Failure Circulation, August 7, 2001; 104(6): 729 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kitaura, N. Tsunekawa, and H. Hatta Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol J Appl Physiol, July 1, 2001; 91(1): 85 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Aschenbach, G. L. Brower, R. J. Talmadge, J. L. Dobson, and L. B. Gladden Effect of a myocardial volume overload on lactate transport in skeletal muscle sarcolemmal vesicles Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R176 - R186. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, M. Tonouchi, D. Miskovic, C. Heddle, J. J. Heikkila, and A. P. Halestrap Isoform-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1131 - E1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Eydoux, G. Py, K. Lambert, H. Dubouchaud, C. Prefaut, and J. Mercier Training does not protect against exhaustive exercise-induced lactate transport capacity alterations Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1045 - E1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, D. Miskovic, M. Tonouchi, K. Lemieux, M. C. Wilson, A. Marette, and A. P. Halestrap Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1067 - E1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
|